Celularity Inc.
CELU · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $54,220 | $22,771 | $17,975 | $21,335 |
| % Growth | 138.1% | 26.7% | -15.7% | – |
| Cost of Goods Sold | $14,989 | $16,016 | $19,665 | $9,653 |
| Gross Profit | $39,231 | $6,755 | -$1,690 | $11,682 |
| % Margin | 72.4% | 29.7% | -9.4% | 54.8% |
| R&D Expenses | $17,386 | $30,465 | $78,363 | $88,353 |
| G&A Expenses | $58,620 | $50,532 | $65,858 | $0 |
| SG&A Expenses | $58,643 | $50,576 | $66,021 | $71,341 |
| Sales & Mktg Exp. | $23 | $44 | $163 | $0 |
| Other Operating Expenses | $1,560 | $118,001 | -$120,474 | -$38,953 |
| Operating Expenses | $77,589 | $199,042 | $23,910 | $120,741 |
| Operating Income | -$38,358 | -$192,287 | -$25,600 | -$109,059 |
| % Margin | -70.7% | -844.4% | -142.4% | -511.2% |
| Other Income/Exp. Net | -$19,534 | -$3,998 | $39,805 | $8,961 |
| Pre-Tax Income | -$57,892 | -$196,285 | $14,205 | -$100,098 |
| Tax Expense | $0 | $10 | $13 | $20 |
| Net Income | -$57,892 | -$196,295 | $14,192 | -$100,118 |
| % Margin | -106.8% | -862% | 79% | -469.3% |
| EPS | -2.645 | -11.02 | 1.014 | -14.93 |
| % Growth | 76% | -1,186.3% | 106.8% | – |
| EPS Diluted | -2.645 | -11.02 | 0.947 | -14.93 |
| Weighted Avg Shares Out | 21,891 | 17,813 | 13,991 | 6,706 |
| Weighted Avg Shares Out Dil | 21,891 | 17,813 | 14,983 | 6,706 |
| Supplemental Information | – | – | – | – |
| Interest Income | $331 | $320 | $365 | $332 |
| Interest Expense | $6,264 | $3,015 | $0 | $3,171 |
| Depreciation & Amortization | $7,922 | $9,324 | $9,436 | $8,817 |
| EBITDA | -$43,706 | -$183,946 | -$138,831 | -$88,110 |
| % Margin | -80.6% | -807.8% | -772.4% | -413% |